Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma-Reference-Cited by-同舟云学术

Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma

Published:2019 Issue:2 Volume:66 Page:187-192
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Abe Ichiro¹,Fujii Hideyuki¹,Ohishi Hanako¹,Sugimoto Kaoru¹,Minezaki Midori¹,Nakagawa Midori¹,Takahara Saori¹,Kudo Tadachika¹,Abe Makiko²³,Ohe Kenji⁴,Yanase Toshihiko⁵,Kobayashi Kunihisa¹

Affiliation:

1. Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka 818-8502, Japan

2. Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka 812-8582, Japan

3. Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, Fukuoka 812-8582, Japan

4. Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan

5. Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/66/2/66_EJ18-0407/_pdf

Reference21 articles.

1. 1 Walther MM, Keiser HR, Linehan WM (1999) Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 17: 35–39.

2. 2 Reisch N, Peczkowska M, Januszewicz A, Neumann HP (2006) Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 24: 2331–2339.

3. 3 Turnbull DM, Johnston DG, Alberti KG, Hall R (1980) Hormonal and metabolic studies in a patient with a pheochromocytoma. J Clin Endocrinol Metab 51: 930–933.

4. 4 Stenstrom G, Sjostrom L, Smith U (1984) Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma. Acta Endocrinol (Copenh) 106: 511–515.

5. 5 Colwell JA (1969) Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann Intern Med 71: 251–256.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Main mechanisms and clinical implications of alterations in energy expenditure state among patients with pheochromocytoma and paraganglioma: A review;Medicine;2024-04-26

2. Risk factors and a predictive nomogram for hemodynamic instability during adrenalectomy for large pheochromocytomas and paragangliomas: A retrospective cohort study;European Journal of Surgical Oncology;2023-10

3. Secondary diabetes mellitus in pheochromocytomas and paragangliomas;Endocrine;2023-09-20

4. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas;Annals of Medicine;2023-04-27

5. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma;International Journal of Molecular Sciences;2023-03-08